Abiopharma

New Form 15-12G - Third Harmonic Bio, Inc. Filed: 2025-08-11 AccNo: 0001193125-25-177392 Size: 11 KB

New Form EFFECT - DiaMedica Therapeutics Inc. Filed: 2025-08-08 AccNo: 9999999995-25-002540 Size: 1 KB

New Form 6-K - BELITE BIO, INC Filed: 2025-08-11 AccNo: 0001104659-25-075837 Size: 109 KB

New Form 6-K - Nyxoah SA Filed: 2025-08-11 AccNo: 0001104659-25-075831 Size: 104 KB

New Form EFFECT - Longeveron Inc. Filed: 2025-08-08 AccNo: 9999999995-25-002544 Size: 1 KB

Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

FDA approve ERIBULIN MESYLATE

FDA approve FENOFIBRATE